Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B trial.

Journal: The lancet. HIV

Publication Year: 2022

Authors & Co-authors:  Madhi Shabir A SA Moodley Dhayendre D Hanley Sherika S Archary Moherndran M Hoosain Zaheer Z Lalloo Umesh U Louw Cheryl C Fairlie Lee L Fouche Leon Frederik LF Masilela Mduduzi S L MSL